Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Donata Benedetti

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Plos One|August 13, 2015
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis PatientsMassimiliano Calabrese, Richard Reynolds, Roberta Magliozzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 1, 2021
Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational studyLoredana La Mantia, Maria Donata Benedetti, Milena Sant, et al.
Plos One|November 18, 2014
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trialLuca Massacesi, Irene Tramacere, Salvatore Amoroso, et al.
Multiple Sclerosis and Related Disorders|February 21, 2020
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, ItalyAntonio Marangi, Gabriele Farina, Virginia Vicenzi, et al.
Journal of Neurology|February 5, 2013
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective studyRoberto D'Alessandro, Luca Vignatelli, Alessandra Lugaresi, et al.
Journal of Neuroimmunology|May 23, 2020
Diagnostic features of initial demyelinating events associated with serum MOG-IgGRiccardo Orlandi, Sara Mariotto, Sergio Ferrari, et al.
Frontiers in Neurology|November 9, 2018
Effects of High-intensity Robot-assisted Hand Training on Upper Limb Recovery and Muscle Activity in Individuals With Multiple Sclerosis: A Randomized, Controlled, Single-Blinded TrialMarialuisa Gandolfi, Nicola Valè, Eleonora Kirilova Dimitrova, et al.
Annals of Neurology|March 9, 2018
Inflammatory intrathecal profiles and cortical damage in multiple sclerosisRoberta Magliozzi, Owain W Howell, Richard Nicholas, et al.
Journal of Neurology|October 25, 2017
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter studySara Mariotto, Sergio Ferrari, Salvatore Monaco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 27, 2020
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter studyFrancesco Patti, Clara Grazia Chisari, Claudio Solaro, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Plos One|August 13, 2015
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis PatientsMassimiliano Calabrese, Richard Reynolds, Roberta Magliozzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 1, 2021
Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational studyLoredana La Mantia, Maria Donata Benedetti, Milena Sant, et al.
Plos One|November 18, 2014
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trialLuca Massacesi, Irene Tramacere, Salvatore Amoroso, et al.
Multiple Sclerosis and Related Disorders|February 21, 2020
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, ItalyAntonio Marangi, Gabriele Farina, Virginia Vicenzi, et al.
Journal of Neurology|February 5, 2013
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective studyRoberto D'Alessandro, Luca Vignatelli, Alessandra Lugaresi, et al.
Journal of Neuroimmunology|May 23, 2020
Diagnostic features of initial demyelinating events associated with serum MOG-IgGRiccardo Orlandi, Sara Mariotto, Sergio Ferrari, et al.
Frontiers in Neurology|November 9, 2018
Effects of High-intensity Robot-assisted Hand Training on Upper Limb Recovery and Muscle Activity in Individuals With Multiple Sclerosis: A Randomized, Controlled, Single-Blinded TrialMarialuisa Gandolfi, Nicola Valè, Eleonora Kirilova Dimitrova, et al.
Annals of Neurology|March 9, 2018
Inflammatory intrathecal profiles and cortical damage in multiple sclerosisRoberta Magliozzi, Owain W Howell, Richard Nicholas, et al.
Journal of Neurology|October 25, 2017
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter studySara Mariotto, Sergio Ferrari, Salvatore Monaco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 27, 2020
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter studyFrancesco Patti, Clara Grazia Chisari, Claudio Solaro, et al.
Pageof 4